Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.

Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL.

PLoS Pathog. 2006 Mar;2(3):e25. Epub 2006 Mar 31. Retraction in: PLoS Pathog. 2012 Sep;8(9). doi: 10.1371/annotation/7e2efc01-2e9b-4e9b-aef0-87ab0e4e4732.

2.

Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer.

Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, Schlomm T.

J Clin Virol. 2008 Nov;43(3):277-83. doi: 10.1016/j.jcv.2008.04.016. Epub 2008 Sep 27.

PMID:
18823818
3.

Identification of viral infections in the prostate and evaluation of their association with cancer.

Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, Garza-Guajardo R, Johnson-Pais T, Beuten J, Morales-Rodriguez IB, Hernandez-Ordoñez MA, Calderon-Cardenas G, Ortiz-Lopez R, Rivas-Estilla AM, Ancer-Rodriguez J, Rojas-Martinez A.

BMC Cancer. 2010 Jun 24;10:326. doi: 10.1186/1471-2407-10-326.

4.

Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients.

Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, Miller K, Kurth R, Bannert N.

Retrovirology. 2009 Oct 16;6:92. doi: 10.1186/1742-4690-6-92.

5.

Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer.

Kim S, Kim N, Dong B, Boren D, Lee SA, Das Gupta J, Gaughan C, Klein EA, Lee C, Silverman RH, Chow SA.

J Virol. 2008 Oct;82(20):9964-77. doi: 10.1128/JVI.01299-08. Epub 2008 Aug 6.

6.

No association of xenotropic murine leukemia virus-related viruses with prostate cancer.

Switzer WM, Jia H, Zheng H, Tang S, Heneine W.

PLoS One. 2011 May 4;6(5):e19065. doi: 10.1371/journal.pone.0019065.

7.

XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.

Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16351-6. doi: 10.1073/pnas.0906922106. Epub 2009 Sep 8. Retraction in: Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12270.

9.
10.

No evidence of XMRV in prostate cancer cohorts in the Midwestern United States.

Sakuma T, Hué S, Squillace KA, Tonne JM, Blackburn PR, Ohmine S, Thatava T, Towers GJ, Ikeda Y.

Retrovirology. 2011 Mar 29;8:23. doi: 10.1186/1742-4690-8-23.

11.

No association between XMRV or related gammaretroviruses in Australian prostate cancer patients.

Rezaei SD, Hearps AC, Mills J, Pedersen J, Tachedjian G.

Virol J. 2013 Jan 10;10:20. doi: 10.1186/1743-422X-10-20.

12.

Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cells.

Bhosle S, Suppiah S, Molinaro R, Liang Y, Arnold R, Diehl W, Makarova N, Blackwell J, Petros J, Liotta D, Hunter E, Ly H.

J Virol. 2010 Jul;84(13):6288-96. doi: 10.1128/JVI.00274-10. Epub 2010 Apr 21.

13.

XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH.

Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, Johnson NA, Bhosle SM, Liotta D, Hunter E, Marshall FF, Ly H, Molinaro RJ, Blackwell JL, Petros JA.

Urology. 2010 Apr;75(4):755-61. doi: 10.1016/j.urology.2010.01.038.

PMID:
20371060
14.

Xenotropic Murine Leukemia Virus-Related Virus and RNase L R462Q Variants in Iranian Patients With Sporadic Prostate Cancer.

Babaei F, Ahmadi A, Rezaei F, Jalilvand S, Ghavami N, Mahmoudi M, Abiri R, Kondori N, Nategh R, Mokhtari Azad T.

Iran Red Crescent Med J. 2015 Dec 19;17(12):e19439. doi: 10.5812/ircmj.19439. eCollection 2015 Dec.

15.

An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors.

Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH.

Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1655-60. Epub 2007 Jan 18.

16.

[RNase L, a crucial mediator of innate immunity and other cell functions].

Bisbal C, Salehzada T.

Med Sci (Paris). 2008 Oct;24(10):859-64. doi: 10.1051/medsci/20082410859. French.

17.

Molecular and phylogenetic analyses of a new amphotropic murine leukemia virus (MuLV-1313).

Howard TM, Sheng Z, Wang M, Wu Y, Rasheed S.

Virol J. 2006 Dec 5;3:101.

18.
19.

[Investigation of the role of ribonuclease L gene in the response of tonsil tissues against viral infections].

Sahin F, Taşpinar M, Karasartova D, Ozkul A, Gerçeker D.

Mikrobiyol Bul. 2006 Oct;40(4):307-15. Turkish.

PMID:
17205688
20.

Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.

Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, Carpten JD, Trent JM, Isaacs WB, Casey G, Silverman RH.

Cancer Res. 2003 Oct 15;63(20):6795-801.

Items per page

Supplemental Content

Write to the Help Desk